Multi-centre randomised controlled trial to evaluate the clinical and cost-effectiveness of a culturally adapted therapy (C-MAP) in patients with a history of self-harm

This website will not work correctly in Internet Explorer 11 and it is strongly recommended that you upgrade to an up-to-date browser. Internet Explorer 11 will go out of support and be retired on June 15, 2022. For more information on upgrading please see browser-update.org.